TMFang4apples

Cory Renauer

TMFang4apples’ Activity

Sun Feb 19

CAPS Outperform Pitch

TMFang4apples wrote about Rigel Pharmaceuticals (RIGL) . 3:57 PM

RIGL Outperform

I think the FDA will accept combined data for fostamatinib in ITP. The company probably should have aimed for a different primary endpoint, but overall it looks like a good drug with a solid future in an orphan population with unmet need.

Caps Pick

TMFang4apples made a pick in CAPS. 3:57 PM

Rigel Pharmaceuticals (RIGL) will Outperform the S&P 500

CAPS Outperform Pitch

TMFang4apples wrote about CVS Health (CVS) . 12:31 PM

CVS Outperform

It has a wide economic moat, and its cheap.

Caps Pick

TMFang4apples made a pick in CAPS. 12:31 PM

CVS Health (CVS) will Outperform the S&P 500

Thu Feb 9

NL

Article

crenauer published an article 5:02 PM

Why I Just Bought More Shares of Gilead Sciences, Inc.

Gilead Sciences' discouraging forward outlook has plenty of investors running for the exits. Here’s why I took another step in the opposite direction.

NL

Article

crenauer published an article 3:34 PM

Here's Why Array Biopharma Inc Stock Is Climbing Again Today

Encouraging progress for the biotech's clinical-stage pipeline kept enthusiastic investors coming back for more.

Tue Feb 7

NL

Article

crenauer published an article 12:25 PM

Here's Why Anavex Life Sciences Corp. Surged Today

Fiscal first-quarter 2017 earnings gave investors some signs of encouragement.

Mon Feb 6

NL

Article

crenauer published an article 1:19 PM

Why Sarepta Therapeutics, Inc. Stock Rose 13.2% in January

Solid fourth-quarter sales figures for Exondys 51 and an upbeat outlook drove up the biotech stock last month.

NL

Article

crenauer published an article 1:07 PM

Is This Why Juno Therapeutics, Inc. Stock Rose 13% in January?

Despite a lack of significant news, this CAR-T stock enjoyed a nice lift last month.

NL

Article

crenauer published an article 12:58 PM

Why Endologix, Inc. Stock Gained 20% in January

It's been a dark time for the medical device maker, but some lights at the end of the tunnel gave investors a reason to cheer last month.

NL

Article

crenauer published an article 12:43 PM

Why Kite Pharma, Inc. Stock Rose 13% in January

Despite a lack of significant news, this clinical-stage biotech stock had a volatile month.

Thu Feb 2

NL

Article

crenauer published an article 12:00 PM

Why Forward Pharma A/S Stock Surged 107% in January

A windfall settlement with Biogen is great news, but is there any more upside?

Tue Jan 31

CAPS Outperform Pitch

TMFang4apples wrote about Ligand Pharmaceuticals (LGND) . 11:47 AM

LGND Outperform

A bazillion drugs in development with its proprietary tech. Best of all commercial launch execution risk is nearly all on Ligand's partners. I'd like a bit lower price, but I still think it can beat the broad market starting at $102 per share.

Caps Pick

TMFang4apples made a pick in CAPS. 11:47 AM

Ligand Pharmaceuticals (LGND) will Outperform the S&P 500

CAPS Outperform Pitch

TMFang4apples wrote about Teva Pharmaceutical Industries (TEVA) . 11:45 AM

TEVA Outperform

I think Copaxone competition is significant but overblown. The company is still highly profitable without it, and extremely cheap now.

Caps Pick

TMFang4apples made a pick in CAPS. 11:45 AM

Teva Pharmaceutical Industries (TEVA) will Outperform the S&P 500
NL

Article

crenauer published an article 11:30 AM

Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?

After sliding for a year, is Teva stock in finally in deep value territory, or is the latest patent issue insurmountable?

Mon Jan 30

NL

Article

crenauer published an article 2:10 PM

3 Stocks That Could Make You Rich

If you like to play it safe, risky, or somewhere in between, you'll want to look closer at these three stocks.

Sun Jan 29

NL

Article

crenauer published an article 3:43 PM

Danger Lurks for These 3 High-Yield Dividend Stocks

These stocks pay a nice yield now, but troubling trends could force these companies to slash their payouts.

Fri Jan 27

NL

Article

crenauer published an article 1:20 PM

How Risky Is CVS Health Corporation?

Outstanding dividend growth and a unique position in America's enormous healthcare sector make CVS Health look like a long-term investor's dream. Here's a look at the risks.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 62.06
Player Rank 28312 out of 74623
Score 155.84
Score Change Today +23.42
Accuracy 53.61%
Active Picks 21
Total Picks 105
Best Pick NPSP.DL (+169.80)
Worst Pick NSPH (-121.59)
Average Score per Pick 1.48
Charms Earned 1
Highest Rated Favorite TMFBiologyFool
Go to TMFang4apples’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFang4apples’ 10 Latest Posts